{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.196.11.1237",
  "meta" : {
    "versionId" : "66",
    "lastUpdated" : "2023-01-27T01:03:21.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "NCQA PHEMUR Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2023-01-27"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2023-01-27"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1237",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.464.1003.196.11.1237"
    }
  ],
  "version" : "20230127",
  "name" : "Carbinoxamine",
  "title" : "Carbinoxamine",
  "status" : "active",
  "date" : "2023-01-27T01:03:21-05:00",
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for carbinoxamine.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable carbinoxamine.),(Exclusion Criteria: Excludes concepts that represent non-prescribable, branded drugs and excludes concepts that represent components or ingredients and carbinoxamine in combination with other medications.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "1010696",
            "display" : "carbinoxamine maleate 0.8 MG/ML Oral Solution"
          },
          {
            "code" : "1012904",
            "display" : "carbinoxamine maleate 4 MG Oral Tablet"
          },
          {
            "code" : "1374770",
            "display" : "12 HR carbinoxamine maleate 0.8 MG/ML Extended Release Suspension"
          },
          {
            "code" : "1795581",
            "display" : "carbinoxamine maleate 6 MG Oral Tablet"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:33362b5a-f257-430b-9689-9e0feaf1ffb0",
    "timestamp" : "2023-11-26T21:03:47-05:00",
    "total" : 4,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "1010696",
        "display" : "carbinoxamine maleate 0.8 MG/ML Oral Solution"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "1012904",
        "display" : "carbinoxamine maleate 4 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "1374770",
        "display" : "12 HR carbinoxamine maleate 0.8 MG/ML Extended Release Suspension"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11062023",
        "code" : "1795581",
        "display" : "carbinoxamine maleate 6 MG Oral Tablet"
      }
    ]
  }
}
